Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meng Hsuan Kuo

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2026
TNF-α Inhibitors and HBV Reactivation Risk in HBsAg-/Anti-HBc+ Patients: A Systematic Review and Meta-AnalysisMeng Hsuan Kuo, Ping-Hung Ko, Chen-Chou Lee, et al.
Tzu Chi Medical Journal|November 9, 2020
Drug-drug interactions between direct-acting antivirals and statins in the treatment of chronic hepatitis CMeng-Hsuan Kuo, Chih-Wei Tseng, Chi-Hui Lee, et al.
Viruses|January 25, 2025
Incidence of HBV Reactivation in Psoriasis Patients Undergoing Cytokine Inhibitor Therapy: A Single-Center Study and Systematic Review with a Meta-AnalysisMeng Hsuan Kuo, Ping-Hung Ko, Sz-Tsan Wang, et al.
Journal of Clinical Medicine|January 10, 2026
Colchicine Use in Acute Coronary Syndrome: A Systematic Review and Meta-AnalysisHuey Chiat Cheong, Meng Hsuan Kuo, Chih-Wei Tseng, et al.
Viruses|January 23, 2024
The Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Receiving Tocilizumab: A Systematic Review and Meta-AnalysisPing-Hung Ko, Meng Hsuan Kuo, I-Ting Kao, et al.
Scientific Reports|February 14, 2020
Moderate Risk of Hepatitis B Virus Reactivation in HBsAg<sup>-</sup>/HBcAb<sup>+</sup> Carriers Receiving Rituximab for Rheumatoid ArthritisMeng Hsuan Kuo, Chih-Wei Tseng, Chi-Hui Lee, et al.
Cancers|May 13, 2023
Prevalence and Effect of Low Skeletal Muscle Mass among Hepatocellular Carcinoma Patients Undergoing Systemic Therapy: A Systematic Review and Meta-AnalysisMeng-Hsuan Kuo, Chih-Wei Tseng, Ching-Sheng Hsu, et al.
Cancers|January 23, 2024
Impact of Low Muscle Mass on Hepatocellular Carcinoma Patients Undergoing Transcatheter Liver-Directed Therapies: Systematic Review & Meta-AnalysisYen-Chun Chen, Meng-Hsuan Kuo, Ching-Sheng Hsu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2025
The Relationship Between TNF-α Inhibitor Potency and HBV Reactivation in Patients With Rheumatic DisordersMeng Hsuan Kuo, Chih-Wei Tseng, Kuo-Chih Tseng, et al.
Digestive Diseases and Sciences|January 2, 2021
Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing TreatmentMeng Hsuan Kuo, Chih-Wei Tseng, Ming-Chi Lu, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2026
TNF-α Inhibitors and HBV Reactivation Risk in HBsAg-/Anti-HBc+ Patients: A Systematic Review and Meta-AnalysisMeng Hsuan Kuo, Ping-Hung Ko, Chen-Chou Lee, et al.
Tzu Chi Medical Journal|November 9, 2020
Drug-drug interactions between direct-acting antivirals and statins in the treatment of chronic hepatitis CMeng-Hsuan Kuo, Chih-Wei Tseng, Chi-Hui Lee, et al.
Viruses|January 25, 2025
Incidence of HBV Reactivation in Psoriasis Patients Undergoing Cytokine Inhibitor Therapy: A Single-Center Study and Systematic Review with a Meta-AnalysisMeng Hsuan Kuo, Ping-Hung Ko, Sz-Tsan Wang, et al.
Journal of Clinical Medicine|January 10, 2026
Colchicine Use in Acute Coronary Syndrome: A Systematic Review and Meta-AnalysisHuey Chiat Cheong, Meng Hsuan Kuo, Chih-Wei Tseng, et al.
Viruses|January 23, 2024
The Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Receiving Tocilizumab: A Systematic Review and Meta-AnalysisPing-Hung Ko, Meng Hsuan Kuo, I-Ting Kao, et al.
Scientific Reports|February 14, 2020
Moderate Risk of Hepatitis B Virus Reactivation in HBsAg<sup>-</sup>/HBcAb<sup>+</sup> Carriers Receiving Rituximab for Rheumatoid ArthritisMeng Hsuan Kuo, Chih-Wei Tseng, Chi-Hui Lee, et al.
Cancers|May 13, 2023
Prevalence and Effect of Low Skeletal Muscle Mass among Hepatocellular Carcinoma Patients Undergoing Systemic Therapy: A Systematic Review and Meta-AnalysisMeng-Hsuan Kuo, Chih-Wei Tseng, Ching-Sheng Hsu, et al.
Cancers|January 23, 2024
Impact of Low Muscle Mass on Hepatocellular Carcinoma Patients Undergoing Transcatheter Liver-Directed Therapies: Systematic Review & Meta-AnalysisYen-Chun Chen, Meng-Hsuan Kuo, Ching-Sheng Hsu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2025
The Relationship Between TNF-α Inhibitor Potency and HBV Reactivation in Patients With Rheumatic DisordersMeng Hsuan Kuo, Chih-Wei Tseng, Kuo-Chih Tseng, et al.
Digestive Diseases and Sciences|January 2, 2021
Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing TreatmentMeng Hsuan Kuo, Chih-Wei Tseng, Ming-Chi Lu, et al.
Pageof 2